Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum

Archives of Dermatology

Volumn 140, Issue 12, 2004, Pages 1427-1429

  Daniels, Natalie Houston ^a   Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DAPSONE; DIPHENHYDRAMINE; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CROHN DISEASE; CUSHINGOID SYNDROME; DRUG EFFICACY; DYSPNEA; FEMALE; HUMAN; ILEOSTOMY; IMMUNOSUPPRESSIVE TREATMENT; JEJUNUM ULCER; NAUSEA; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; STOMA; ULCER HEALING;

ADOLESCENT; COLONIC POUCHES; CROHN DISEASE; FEMALE; HUMANS; ILEOSTOMY; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; PYODERMA GANGRENOSUM; RECTAL FISTULA; REOPERATION;

EID: 10344231534     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.12.1427     Document Type: Article

References (13)

1. Keltz M, Lebwohl M, Bishop S. Peristomal pyoderma gangrenosum. J Am Acad Dermatol. 1992;27:360-364.
2. Callen JP, Hughes AP, Jackson MJ. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA. 2000;284:1546-1548.
3. Callen JP. Pyoderma gangrenosum. Lancet. 1998;351:581-585.
4. Cairns BA, Herbst CA, Sartor BR, Briggaman RA, Koruda MJ. Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg. 1994;129: 769-772.
5. Sheldon DG, Sawchuk LL, Kozarek RA, Thirlby RC. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg. 2000;135:564-569.
6. Lyon CC, Smith AJ, Beck MH, Wong GA, Griffiths CE. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol. 2000;42: 992-1002.
7. Batres LA, Mamula P, Baldassano RN. Resolution of severe peristomal pyoderma gangrenosum with inflixamab in a child with Crohn's disease. J Pediatr Gastroenterol Nutr. 2002;34:558-560.
8. Lipsky JJ. Mycophenolate mofetil. Lancet. 1996;348:1357-1359.
9. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanism of action. Immunopharmacology. 2000;47:85-118.
10. Nousari HC, Lynch W, Anhalt GJ, Petri M. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol. 1998;134:1509-1511.
11. Gilmour E, Stewart DG. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis. Br J Dermatol. 2001;144:397-400.
12. Michel S, Hohenleutner MS, Mohr U, Landthaler M. Therapy-resistant pyoderma gangrenosum-treatment with mycophenolate mofetil and cyclosporine A. Hautarzt. 1999;50:428-431.
13. Le Hello C, Bonte I, Mora JJ, Noel LH, Guillevin L. Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil. Rheumatology. 2002;41:236-237.